Latest Breaking News On - Arrhythmia services - Page 2 : comparemela.com

Medtronic (MDT) Sphere-360 PFA catheter demonstrates impressive results in treating paroxysmal atrial fibrillation

Medtronic (MDT) Sphere-360 PFA catheter demonstrates impressive results in treating paroxysmal atrial fibrillation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Khaldoun tarakjiVivek reddyIcahn school of medicine at mount sinaiArrhythmia servicesEuropean heart rhythm associationAblation solutionsAblation systemCardiac arrhythmia servicesIcahn schoolMount sinaiAffera mappingCardiac ablation solutionsCardiovascular portfolioAffera mapping system

Pulse Biosciences, Inc : Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX nsPFA 360° Cardiac Catheter First-in-Human Feasibility Study

Pulse Biosciences, Inc : Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX nsPFA 360° Cardiac Catheter First-in-Human Feasibility Study
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Czech republicUnited statesKevin danahyStefan klotterVivek reddyGilmartin groupPulse biosciences incCompany cellArrhythmia servicesExchange commissionPulse biosciencesPulsed field ablationCardiac catheter first in human feasibilityCardiac catheterCardiac arrhythmia servicesMount sinai fuster heart hospital

Pulse Biosciences Announces Positive Results For CellFX NsPFA 360 Cardiac Catheter Study; Stock Up

(RTTNews) - Pulse Biosciences, Inc. (PLSE), Wednesday announced positive results from the 60-day post-procedure evaluations of four initial patien.

Vivek reddyPulse biosciences incArrhythmia servicesCatheter first in human feasibilityCardiac arrhythmia servicesMount sinai fuster heart hospitalPulse biosciences

Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study

Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Czech republicUnited statesVivek reddyKevin danahyGilmartin groupCompany cellPulse biosciences incExchange commissionArrhythmia servicesPulsed field ablationCardiac catheter first in human feasibilityCardiac catheterCardiac arrhythmia servicesMount sinai fuster heart hospitalChief executive officerPulse biosciences

Pulse Biosciences Announces Positive Results For CellFX NsPFA 360 Cardiac Catheter Study; Stock Up

Pulse Biosciences, Inc. (PLSE), Wednesday announced positive results from the 60-day post-procedure evaluations of four initial patients with atrial fibrillation in the CellFX nsPFA 360 Cardiac Catheter First-in-Human Feasibility Study.

Vivek reddyArrhythmia servicesPulse biosciences incPulse biosciencesCatheter first in human feasibilityCardiac arrhythmia servicesMount sinai fuster heart hospital